T1	Condition 9 32	hemodynamic instability
T2	Measurement 39 62	systolic blood pressure
T3	Value 63 77	<100 mm Hg.St.
R1	Has_value Arg1:T2 Arg2:T3	
T4	Measurement 92 120	systolic blood pressure fall
T5	Value 125 134	=40 mm Hg
R2	Has_value Arg1:T4 Arg2:T5	
*	OR T2 T4 T6
T6	Measurement 141 151	heart rate
T7	Value 152 157	> 110
R3	Has_value Arg1:T6 Arg2:T7	
T8	Multiplier 158 182	lasting more than 15 min
R4	Has_multiplier Arg1:T6 Arg2:T8	
T9	Procedure 196 215	ventilatory support
T10	Mood 187 195	need for
R5	Has_mood Arg1:T9 Arg2:T10	
T11	Temporal 216 254	within 12 hours prior to randomisation
R6	Has_temporal Arg1:T9 Arg2:T11	
T12	Scope 39 182	systolic blood pressure <100 mm Hg.St. or episode of systolic blood pressure fall for =40 mm Hg. / or heart rate > 110 lasting more than 15 min
R7	Subsumes Arg1:T1 Arg2:T12	
*	OR T1 T9
T13	Procedure 276 296	oral anticoagulation
T14	Mood 261 275	indication for
R8	Has_mood Arg1:T13 Arg2:T14	
T15	Qualifier 331 340	malignant
T16	Condition 341 349	neoplasm
R9	Has_qualifier Arg1:T16 Arg2:T15	
T17	Condition 367 384	Contraindications
T18	Drug 388 396	warfarin
T19	Drug 400 407	pradaxa
*	OR T19 T18
T20	Scope 388 407	warfarin or pradaxa
R10	Has_scope Arg1:T17 Arg2:T20	
T21	Qualifier 421 457	Russian Instructions for medical use
R11	Has_qualifier Arg1:T17 Arg2:T21	
T22	Drug 517 536	antiplatelet agents
T23	Temporal 490 501	concomitant
T24	Mood 474 485	Indications
R12	Has_mood Arg1:T22 Arg2:T24	
R13	Has_temporal Arg1:T22 Arg2:T23	
T25	Condition 542 548	stroke
T26	Temporal 549 585	within 6 months before randomization
R14	Has_temporal Arg1:T25 Arg2:T26	
T27	Condition 587 610	Intracranial hemorrhage
T28	Procedure 614 623	anamnesis
R15	AND Arg1:T28 Arg2:T27	
T29	Condition 632 640	bleeding
T30	Condition 642 660	bleeding diathesis
*	OR T30 T29
T31	Qualifier 663 685	Clinically significant
T32	Condition 686 694	bleeding
T33	Temporal 695 718	within the last 30 days
R16	Has_qualifier Arg1:T32 Arg2:T31	
R17	Has_temporal Arg1:T32 Arg2:T33	
T34	Condition 721 727	Trauma
T35	Procedure 731 748	extensive surgery
T36	Temporal 749 784	within 1 month before randomization
*	OR T34 T35
T37	Scope 721 748	Trauma or extensive surgery
R18	Has_temporal Arg1:T37 Arg2:T36	
T38	Procedure 788 795	surgery
T39	Mood 796 803	planned
T40	Temporal 804 844	in the next 6 months after randomization
R19	Has_temporal Arg1:T38 Arg2:T40	
R20	Has_mood Arg1:T38 Arg2:T39	
*	OR T37 T38
T41	Condition 847 869	Intracranial pathology
T42	Condition 871 876	tumor
T43	Condition 878 899	arteriovenous fistula
T44	Condition 903 911	aneurysm
*	OR T43 T44 T42
T45	Scope 871 911	tumor, arteriovenous fistula or aneurysm
R21	Subsumes Arg1:T41 Arg2:T45	
T46	Condition 914 939	Gastrointestinal bleeding
T47	Temporal 940 964	in the previous 3 months
R22	Has_temporal Arg1:T46 Arg2:T47	
T48	Condition 967 980	Gastric ulcer
T49	Condition 984 998	duodenal ulcer
T50	Condition 1004 1027	clinical manifestations
R23	AND Arg1:T49 Arg2:T50	
*	OR T48 T49 T53
T51	Qualifier 1031 1056	endoscopically identified
T52	Procedure 1031 1045	endoscopically
T53	Condition 1057 1068	acute ulcer
T54	Negation 1069 1076	without
T55	Condition 1077 1094	signs of scarring
T56	Temporal 1095 1118	during previous 30 days
R24	Has_negation Arg1:T55 Arg2:T54	
R25	Has_qualifier Arg1:T53 Arg2:T51	
R26	multi Arg1:T51 Arg2:T52	
R27	AND Arg1:T53 Arg2:T55	
R28	Has_temporal Arg1:T53 Arg2:T56	
T57	Qualifier 1121 1133	Uncontrolled
T58	Condition 1134 1146	hypertension
T59	Measurement 1148 1171	systolic blood pressure
T60	Value 1171 1182	> 180 mm Hg
R29	Has_value Arg1:T59 Arg2:T60	
T61	Measurement 1193 1217	diastolic blood pressure
T62	Value 1217 1228	> 100 mm.hg
R30	Has_value Arg1:T61 Arg2:T62	
*	OR T59 T61
T63	Drug 1251 1273	antihypertensive drugs
T64	Scope 1148 1273	systolic blood pressure> 180 mm Hg. and / or diastolic blood pressure> 100 mm.hg in patients receiving antihypertensive drugs
R31	Has_qualifier Arg1:T58 Arg2:T57	
R32	Subsumes Arg1:T58 Arg2:T64	
T65	Condition 1277 1286	Pregnancy
T66	Condition 1288 1297	lactation
T67	Observation 1300 1315	Life expectancy
T68	Value 1316 1325	<6 months
R33	Has_value Arg1:T67 Arg2:T68	
T69	Qualifier 1328 1350	Clinically significant
T70	Condition 1351 1364	liver disease
R34	Has_qualifier Arg1:T70 Arg2:T69	
T71	Measurement 1367 1387	Creatinine clearance
T72	Qualifier 1402 1417	Cockcroft-Gault
R35	Has_qualifier Arg1:T71 Arg2:T72	
T73	Value 1419 1431	<30 ml / min
R36	Has_value Arg1:T71 Arg2:T73	
T74	Measurement 1434 1450	hemoglobin level
T75	Value 1451 1458	<90 g/l
R37	Has_value Arg1:T74 Arg2:T75	
T76	Condition 1461 1477	thrombocytopenia
T77	Value 1478 1491	<100x10^9 / L
R38	Has_value Arg1:T76 Arg2:T77	
T78	Non-query-able 1494 1664	Patients who, in the opinion of the researcher, are not suitable for inclusion in the study, for example, due to the low likelihood of doctor's recommendations following.
T79	Drug 1683 1689	NSAIDs
T80	Multiplier 1666 1679	Long-term use
R39	Has_multiplier Arg1:T79 Arg2:T80	
T81	Non-query-able 1691 1739	Current participation in another clinical study.
T82	Condition 1741 1749	Allergic
T83	Drug 1753 1771	contrast substance
T84	Drug 1775 1793	radioisotope drugs
*	OR T83 T84
T85	Scope 1753 1793	contrast substance or radioisotope drugs
R40	Has_scope Arg1:T82 Arg2:T85	
T86	Qualifier 625 631	Active
R41	Has_qualifier Arg1:T29 Arg2:T86	
